Sonrotoclax TFA is an orally available and highly potent and selective Bcl-2 inhibitor of WT and G101V mutants with antitumor activity for the study of hematologic malignancies.
Molecular Weight:
1004.12
Purity:
99.63%
Formula:
C51H60F3N7O9S
Target:
Bcl-2 Family
T74637L
* VAT and and shipping costs not included. Errors and price changes excepted